ProQR Therapeutics N.V. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,689.60
136,416.20
103,051.90
62,441.20
57,757.30
120,693.80
Total Accounts Receivable
177.80
911.20
1,632.70
1,650.70
563.20
2,448.60
Other Current Assets
4.10
493.70
1,521.90
1,318.40
2,390.80
737.30
Total Current Assets
5,871.40
137,821.10
106,206.50
65,410.30
60,711.20
123,879.70
Net Property, Plant & Equipment
281.10
1,436.30
2,388.80
3,626.20
3,008.00
2,130.80
Intangible Assets
53.70
197.20
153.20
94.90
46.80
-
Total Assets
6,206.30
139,454.60
108,748.40
69,131.50
63,766.10
126,010.60
ST Debt & Current Portion LT Debt
3,493.10
41.10
16.30
-
2,353.60
Accounts Payable
1,026.60
1,508.90
961.40
346.00
655.60
Other Current Liabilities
443.70
2,097.00
4,981.80
6,731.40
7,190.40
Total Current Liabilities
4,963.40
3,647.10
5,959.40
7,077.40
10,199.60
Long-Term Debt
1,336.60
3,423.20
5,240.30
4,849.70
6,345.00
Other Liabilities
28.90
-
-
1,159.20
-
Total Liabilities
6,328.90
7,070.30
11,199.80
13,086.30
16,544.60
Common Equity (Total)
122.60
132,384.30
97,548.70
56,045.20
47,267.10
Total Shareholders' Equity
122.60
132,384.30
97,548.70
56,045.20
47,267.10
Total Equity
122.60
132,384.30
97,548.70
56,045.20
47,221.50
Liabilities & Shareholders' Equity
6,206.30
139,454.60
108,748.40
69,131.50
63,766.10
Accumulated Minority Interest
-
-
-
-
45.60
About ProQR Therapeutics
View Profile
